Literature DB >> 28288988

Circulating Biomarkers of Cardiac Fibrosis: Do We Have Any and What Use Are They?

A Mark Richards1.   

Abstract

Entities:  

Keywords:  Editorials; biomarkers; collagen; fibrosis; heart failure; myocardial infarction

Mesh：

Substances：

Year:  2017        PMID： 28288988     DOI： 10.1161/CIRCHEARTFAILURE.117.003936

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  3 in total

1.  Simple Predictors for Cardiac Fibrosis in Patients with Type 2 Diabetes Mellitus: The Role of Circulating Biomarkers and Pulse Wave Velocity.

Authors:  Ekaterina B Luneva; Anastasia A Vasileva; Elena V Karelkina; Maria A Boyarinova; Evgeny N Mikhaylov; Anton V Ryzhkov; Alina Y Babenko; Alexandra O Konradi; Olga M Moiseeva
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

2.  Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction.

Authors:  Giovanni Battista Bolla; Antonella Fedele; Andrea Faggiano; Carla Sala; Gloria Santangelo; Stefano Carugo
Journal:  BMC Cardiovasc Disord       Date:  2022-05-13       Impact factor: 2.174

Review 3.  Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease.

Authors:  Linsey J F Peters; Erik A L Biessen; Mathias Hohl; Christian Weber; Emiel P C van der Vorst; Donato Santovito
Journal:  Front Physiol       Date:  2020-07-07       Impact factor: 4.566
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.